![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Synthon Bv Nijmegen Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Flumazenil, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2015-253 - Rev 00
This Chemical Type CEP, issued on May 24, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1326 associated with this CEP further emphasizes